Merit Financial Group’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$326K Buy
3,288
+1,033
+46% +$125K ﹤0.01% 1857
2026
Q2
$301K Buy
2,255
+18
+0.8% +$2.04K ﹤0.01% 1810
2026
Q1
$249K Buy
2,237
+181
+9% +$21.4K ﹤0.01% 1774
2025
Q4
$277K Buy
+2,056
New +$224K ﹤0.01% 1603

Other funds holding ABVX

Merit Financial Group's ABVX Position: Q3 2026 in Review

Merit Financial Group increased its Abivax (ABVX) stake by 46% in Q3 2026, buying an estimated $125K and bringing the position to 3,288 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #1857.

Merit Financial Group first reported a position in ABVX in Q4 2025 and has held it in 4 quarters since. 319 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Merit Financial Group held 3,288 shares of Abivax worth $326K as of Q3 2026.
  • Merit Financial Group bought 1,033 Abivax shares in Q3 2026, an estimated $125K.
  • Abivax made up ﹤0.01% of Merit Financial Group's portfolio in Q3 2026, its #1857 holding.
  • Merit Financial Group first reported a position in Abivax in Q4 2025 and has held it in 4 quarters since.
  • 319 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Merit Financial Group's 13F filing for Q3 2026, filed 6 Nov 2026.